Ortgies Tjark, Rullmann Michael, Ziegelhöfer Dorothée, Bläser Annett, Thome Ulrich H
Division of Neonatology, University Children's Hospital Leipzig, Liebigstraße 20, 04103, Leipzig, Germany.
Department of Nuclear Medicine, University Hospital Leipzig, Liebigstraße 18, 04103, Leipzig, Germany.
BMC Pediatr. 2021 Jun 25;21(1):289. doi: 10.1186/s12887-021-02738-5.
The study investigated a putative association between early-onset-sepsis (EOS) and poor neurodevelopmental outcomes at 2 years corrected age in very low birth weight infants.
This was a single-center cohort study on infants weighing less than 1500 g with a gestational age below 35 weeks at birth born between 2008 and 2011. Neurodevelopmental outcomes were assessed at follow-up with the Bayley Scales of Infant Development-II. EOS was defined as either culture-proven EOS or clinical EOS using blood culture, CrP levels, and clinical symptoms and treatment. Neurodevelopmental impairment (NDI) was defined as one or more of the following: Mental Developmental Index (MDI) and/or Psychomotor Developmental Index (PDI) scores lower than 70; presence of cerebral palsy.
Of 405 eligible newborns in the study period 166 were included. Two had culture-proven and 29 clinical EOS. Median MDI scores in patients with EOS were 96 (IQR: 86-106) and in the control group 94 (84-106, p = 0.77). PDI scores in patients with EOS were 96 (86-106) and in the control group 99,5 (92-103, p = 0.03). Of infected patients 7/31 (24%) showed NDI as defined, whereas only 11/135 (8%) showed NDI in the control group (OR 3.3, p = 0.03). Multiple regression analyses identified chorioamnionitis and poor CRIB-Scores as individual risk factors for MDI or PDI values < 70.
In our study, EOS among VLBW-infants significantly impaired the neurodevelopment at 2 years corrected age. As shown in previous reports infection continues to be a problem and strategies for a reduction need further improvement.
本研究调查了极低出生体重儿早发型败血症(EOS)与2岁矫正年龄时神经发育不良结局之间的假定关联。
这是一项对2008年至2011年间出生的出生体重低于1500g、胎龄低于35周的婴儿进行的单中心队列研究。随访时使用贝利婴儿发育量表第二版评估神经发育结局。EOS被定义为经血培养证实的EOS或临床EOS,依据血培养、CrP水平以及临床症状和治疗情况来判定。神经发育障碍(NDI)被定义为以下一项或多项:智力发育指数(MDI)和/或心理运动发育指数(PDI)得分低于70;存在脑瘫。
在研究期间的405名符合条件的新生儿中,166名被纳入研究。2例经血培养证实患有EOS,29例患有临床EOS。EOS患者的MDI中位数得分是96(四分位间距:86 - 106),对照组为94(84 - 106,p = 0.77)。EOS患者的PDI得分是96(86 - 106),对照组为99.5(92 - 103,p = 0.03)。在感染患者中,7/31(24%)表现出所定义的NDI,而对照组中只有11/135(8%)表现出NDI(比值比3.3,p = 0.03)。多元回归分析确定绒毛膜羊膜炎和较差的CRIB评分是MDI或PDI值<70的个体危险因素。
在我们的研究中,极低出生体重儿中的EOS在2岁矫正年龄时显著损害神经发育。如先前报告所示,感染仍然是一个问题,减少感染的策略需要进一步改进。